Ally Bridge Group (Ny) LLC Merus N.V. Transaction History
Ally Bridge Group (Ny) LLC
- $141 Million
- Q3 2024
A detailed history of Ally Bridge Group (Ny) LLC transactions in Merus N.V. stock. As of the latest transaction made, Ally Bridge Group (Ny) LLC holds 208,244 shares of MRUS stock, worth $8.72 Million. This represents 7.39% of its overall portfolio holdings.
Number of Shares
208,244
Previous 174,844
19.1%
Holding current value
$8.72 Million
Previous $10.3 Million
0.56%
% of portfolio
7.39%
Previous 9.7%
Shares
7 transactions
Others Institutions Holding MRUS
# of Institutions
200Shares Held
61.9MCall Options Held
243KPut Options Held
300K-
Rtw Investments, LP New York, NY4.17MShares$175 Million3.32% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.41MShares$143 Million3.17% of portfolio
-
Commodore Capital LP New York, NY3.35MShares$140 Million14.22% of portfolio
-
Wellington Management Group LLP Boston, MA2.89MShares$121 Million0.03% of portfolio
-
Samlyn Capital, LLC New York, NY2.61MShares$109 Million2.1% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $1.92B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...